Carl Zeiss Meditec AG
XETRA:AFX

Watchlist Manager
Carl Zeiss Meditec AG Logo
Carl Zeiss Meditec AG
XETRA:AFX
Watchlist
Price: 41.2 EUR 0.05% Market Closed
Market Cap: 3.7B EUR
Section:
 

Relative Value

The Relative Value of one AFX stock under the Base Case scenario is 86.89 EUR. Compared to the current market price of 41.2 EUR, Carl Zeiss Meditec AG is Undervalued by 53%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AFX Relative Value
Base Case
86.89 EUR
Undervaluation 53%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.6
P/S
P/S
Price to Sales
1.6
vs History
96
vs Industry
38
Median 3Y
2.9
Median 5Y
5
Industry
2.4
Forward
1.6
More Details
25.5
P/E
P/E
Price to Earnings
25.5
vs History
92
vs Industry
14
Median 3Y
30
Median 5Y
34.1
Industry
22.9
Forward
20.1
More Details
17.2
P/OCF
P/OCF
Price to OCF
17.2
vs History
57
vs Industry
15
Median 3Y
18.1
Median 5Y
20
Industry
14.7
More Details
38.3
P/FCFE
P/FCFE
Price to FCFE
38.3
vs History
30
vs Industry
29
Median 3Y
-130.1
Median 5Y
8.7
Industry
21.4
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
96
vs Industry
29
Median 3Y
2.8
Median 5Y
4.8
Industry
2.3
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
96
vs Industry
35
Median 3Y
3.1
Median 5Y
5.1
Industry
2.6
Forward
1.8
More Details
3.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.5
vs History
96
vs Industry
37
Median 3Y
5.8
Median 5Y
8.6
Industry
5.3
More Details
11.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.8
vs History
96
vs Industry
16
Median 3Y
21.9
Median 5Y
27.7
Industry
12.3
Forward
10.4
More Details
18.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18.4
vs History
96
vs Industry
11
Median 3Y
27.3
Median 5Y
29.7
Industry
17.2
Forward
15.7
More Details
19.6
EV/OCF
EV/OCF
Enterprise Value to OCF
19.6
vs History
57
vs Industry
14
Median 3Y
20.5
Median 5Y
22.6
Industry
15
More Details
30.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
30.9
vs History
49
vs Industry
6
Median 3Y
-132.9
Median 5Y
31.2
Industry
19
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
96
vs Industry
36
Median 3Y
2.3
Median 5Y
3.8
Industry
1.9
More Details

Multiples Across Competitors

AFX Competitors Multiples
Carl Zeiss Meditec AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Carl Zeiss Meditec AG
XETRA:AFX
3.6B EUR 1.6 25.5 11.8 18.4
US
Abbott Laboratories
NYSE:ABT
214.4B USD 4.9 15.5 19.6 27.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
200.8B USD 21 73.3 56 68.3
US
Boston Scientific Corp
NYSE:BSX
139.1B USD 7.2 50 29.2 39.7
US
Stryker Corp
NYSE:SYK
136.3B USD 5.6 46.3 22.6 27.4
IE
Medtronic PLC
NYSE:MDT
124.2B USD 3.6 25.9 14.7 21.3
DE
Siemens Healthineers AG
XETRA:SHL
52.3B EUR 2.2 24.3 13.7 19.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57.4B USD 13.8 55.9 40.1 44.4
US
Becton Dickinson and Co
NYSE:BDX
57.9B USD 2.6 34.3 12.7 21.6
US
Edwards Lifesciences Corp
NYSE:EW
48.1B USD 8.3 35.6 25.1 27.5
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.4B USD 1.9 17.8 13.2 16

See Also

Summary
AFX intrinsic value, competitors valuation, and company profile.
DCF Valuation
AFX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AFX stock valuation using valuation multiples.
Wall Street Estimates
AFX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AFX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 309,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.